Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease.
Shepherd J, Kastelein JP, Bittner VA, Carmena R, Deedwania PC, Breazna A, Dobson S, Wilson DJ, Zuckerman AL, Wenger NK; Treating to New Targets Steering Committee and Investigators.
Mayo Clin Proc. 2008 Aug;83(8):870-9.PMID: 18674471 [PubMed - indexed for MEDLINE]Related articlesFree article